rs5745666
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000222390.11(HGF):āc.711T>Cā(p.His237=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00203 in 1,613,994 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.011 ( 31 hom., cov: 32)
Exomes š: 0.0011 ( 25 hom. )
Consequence
HGF
ENST00000222390.11 synonymous
ENST00000222390.11 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.558
Genes affected
HGF (HGNC:4893): (hepatocyte growth factor) This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 7-81745035-A-G is Benign according to our data. Variant chr7-81745035-A-G is described in ClinVar as [Benign]. Clinvar id is 43610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-81745035-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.558 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0106 (1615/152288) while in subpopulation AFR AF= 0.0363 (1506/41540). AF 95% confidence interval is 0.0347. There are 31 homozygotes in gnomad4. There are 794 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 31 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGF | NM_000601.6 | c.711T>C | p.His237= | synonymous_variant | 6/18 | ENST00000222390.11 | NP_000592.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGF | ENST00000222390.11 | c.711T>C | p.His237= | synonymous_variant | 6/18 | 1 | NM_000601.6 | ENSP00000222390 | P4 | |
HGF | ENST00000457544.7 | c.696T>C | p.His232= | synonymous_variant | 6/18 | 1 | ENSP00000391238 | A1 | ||
HGF | ENST00000444829.7 | c.711T>C | p.His237= | synonymous_variant | 6/8 | 1 | ENSP00000389854 | |||
HGF | ENST00000453411.6 | c.696T>C | p.His232= | synonymous_variant | 6/8 | 1 | ENSP00000408270 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1611AN: 152170Hom.: 31 Cov.: 32
GnomAD3 genomes
AF:
AC:
1611
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00272 AC: 684AN: 251244Hom.: 13 AF XY: 0.00206 AC XY: 280AN XY: 135780
GnomAD3 exomes
AF:
AC:
684
AN:
251244
Hom.:
AF XY:
AC XY:
280
AN XY:
135780
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00114 AC: 1665AN: 1461706Hom.: 25 Cov.: 31 AF XY: 0.000967 AC XY: 703AN XY: 727172
GnomAD4 exome
AF:
AC:
1665
AN:
1461706
Hom.:
Cov.:
31
AF XY:
AC XY:
703
AN XY:
727172
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0106 AC: 1615AN: 152288Hom.: 31 Cov.: 32 AF XY: 0.0107 AC XY: 794AN XY: 74470
GnomAD4 genome
AF:
AC:
1615
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
794
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | His237His in Exon 06 of HGF: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 3.4% (126/3736) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs5745666). - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at